To evaluate outcomes of patients achieving <ypT2N0 disease at radical cystectomy (RC) following neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC) to identify an optimal definition of pathologic response.
To evaluate outcomes of patients achieving <ypT2N0 disease at radical cystectomy (RC) following neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC) to identify an optimal definition of pathologic response.